DIA 3rd Annual Clinical Trial Disclosure Workshop Offers Strategies for Creating Effective Registries and Results Databanks

The Drug Information Association (DIA) will host its 3rd Annual Clinical Trial Disclosure Workshop (October 6-8, 2009; National Harbor, MD).

ShareThis Email PDF Print

This workshop will present real-world approaches to the clinical trial registration and results disclosure process.

Horsham, PA, USA (Vocus) August 21, 2009

The Drug Information Association (DIA) will host its 3rd Annual Clinical Trial Disclosure Workshop (October 6-8, 2009; National Harbor, MD).

This three-day workshop will feature interactive discussions with government, biopharmaceutical, medical device, and data standards experts on how to ensure compliance and improve efficiency in clinical trial disclosure.

FEATURED TOPICS

Global Requirements, Laws, Regulations and Business Cases
Defining the Clinical Trial Disclosure Role within a Company
Available Tools, Resources, Organizations
Impact of External Stakeholders, Company Policies, and Advanced Technologies on
Disclosure Processes
Key Milestones for Managing Compliance
Quality Checks

"Evolving clinical trial registration and results disclosure requirements are significantly increasing the workload of clinical operations and medical affairs departments," says Program Co-chair Tracy Beck, PhD, Associate Global Medical Business Office Consultant; CTR Results Gatekeeper, Eli Lilly and Company. "This workshop will present real-world approaches to the clinical trial registration and results disclosure process."

A preconference tutorial titled, Clinical Trial Results Registration, will be held on October 6. This hands-on tutorial is designed to guide participants in creating accurate and effective study results to http://www.ClinicalTrials.gov ].

For tabletop exhibit opportunities contact Jeff Korn at Jeff.Korn(at)diahome(dot)org.

Click here to register for the 3rd Annual Clinical Trial Disclosure Workshop.

About the Drug Information Association (DIA)
DIA serves more than 30,000 professionals involved in the biopharmaceutical industry and regulatory affairs worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit http://www.diahome.org or call 215-442-6100.

Contact:
Joe Krasowski
DIA
+1-215-293-5812
Joe.Krasowski(at)diahome(dot)org

# # #